SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-15-080366
Filing Date
2015-11-20
Accepted
2015-11-20 09:03:36
Documents
8
Effectiveness Date
2015-11-20

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO.1 a15-23658_1posasr.htm POSASR 209827
2 FORM OF GUARANTEED DEBT SECURITY FOR 3.000% NOTES DUE 2025 a15-23658_1ex4d3.htm EX-4.3 81378
3 FORM OF GUARANTEED DEBT SECURITY FOR 4.000% NOTES DUE 2045 a15-23658_1ex4d4.htm EX-4.4 81174
4 OFFICER'S CERTIFICATE OF NOVARTIS CAPITAL CORPORATION a15-23658_1ex4d5.htm EX-4.5 28846
5 OPINION OF MAYER BROWN INTERNATIONAL LLP a15-23658_1ex5d4.htm EX-5.4 23566
6 OPINION OF BAER & KARRER AG a15-23658_1ex5d5.htm EX-5.5 40987
7 GRAPHIC g236581kqi001.gif GRAPHIC 1416
8 GRAPHIC g236581ksi001.jpg GRAPHIC 2513
  Complete submission text file 0001104659-15-080366.txt   473599
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-207004 | Film No.: 151245062
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-207004-02 | Film No.: 151245063
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O.BOX HM 2899 HAMILTON D0 HM LX
Business Address 131 FRONT STREET HAMILTON D0 HM 12 (1)441 296 8025
Novartis Securities Investment Ltd. (Filer) CIK: 0001443663 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-207004-01 | Film No.: 151245064